Related Experiment Videos
Hydroxyurea increases in vitro, antigen-independent B cell development in bone marrow
Clinical and Experimental Immunology
|September 1, 1982
Summary
Hydroxyurea treatment increased B cell numbers in mouse bone marrow cultures by 40-70%. This agent also enhanced B cell responses to mitogens, indicating a role in B cell development.
Area of Science:
- Immunology
- Developmental Biology
- Cell Biology
Background:
- B cell development is a complex process crucial for adaptive immunity.
- Hydroxyurea is a known S-phase specific cytotoxic agent.
- Understanding factors influencing B cell populations is vital for immunological research.
Purpose of the Study:
- To investigate the in vitro effects of hydroxyurea on B cell development.
- To determine if hydroxyurea impacts B cell numbers and function in mouse bone marrow cultures.
Main Methods:
- Utilized fluorescence-activated cell sorting and Coulter counter for cell analysis.
- Cultured adult mouse bone marrow with and without hydroxyurea for 24 hours.
- Assessed B cell numbers and response to bacterial lipopolysaccharide (LPS) mitogen.
Main Results:
- Hydroxyurea treatment resulted in a 40-70% increase in absolute B cell numbers in bone marrow cultures.
- An enhanced response to bacterial lipopolysaccharide was observed, indicated by increased 3H-thymidine incorporation.
- Hydroxyurea increased B cell numbers in fetal liver but not in lymph nodes or spleen.
Conclusions:
- Hydroxyurea can promote B cell proliferation and/or survival in vitro.
- The observed effects are likely due to the S-phase targeting nature of hydroxyurea, potentially by eliminating competing cell populations.
- These findings suggest hydroxyurea's potential role in modulating B cell populations during development.